Trimethoprim (TM) (2,4-diamino-5-(3,4,5-trimethoxybenzyl)-pyrimidine) is an antibacterial agent. It blocks the folic acid synthesis of bacteria in the manner of the sulphonamides, but acts at a different stage in the synthesis. TM and sulphonamides have a synergistic effect (Bushby and Hitchings, i968), and thus a combination ofTM and sulphonamide has a broad-spectrum bactericidal action (B6hni, I969). The sulphonamide used in combined preparations has been sulphamethoxazole (SMZ) which in man has practically the same rate of secretion and elimination as TM, the half-life of both being approximately io hrs (Rieder, I963; Schwartz and Ziegler, I969).
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TM and SMZ have been found to diffuse well into different tissues (Schwartz and Rieder, 1970) and it therefore seemed possible that they would also penetrate the bloodaqueous barrier. The purpose of our work was to study this question in rabbit and human eyes.
Methods
The experiments on the test animals were conducted in the Research Centre Liiiike-Medipolar, Turku. The test animals were eight male albino rabbits weighing 2-5-3.9 kg. They were given 20 mg.
TM and Ioo mg. SMZ per kg. body weight in a single oral dose. The aqueous sample and the blood sample from the auricular vein were taken from four rabbits I hour and from the other four 2 hours after administration of the drug. Puncture of the anterior chamber was performed at the limbus, using a disposable No. I8 needle. The animals were anaesthetized with nembutal for the sampling.
The human samples were taken at the Eye Department of the Regional Hospital, Lahti. An oral dose of I6o mg. TM and 8oo mg. SMZ (Trimosulfa, Laake Oy) was given to six patients the evening before surgery for cataract and was repeated on the following morning. Before the first dose, blood was drawn from the cubital vein for the control sample, and 2 hours after the second dose, during the cataract operation, about 0-2 ml. aqueous was withdrawn under retrobulbar anaesthesia. The aqueous was drawn off with a disposable No. I8 needle which was inserted through the cornea at the limbus. The amount of fluid removed was replaced with physiological saline and the cataract extraction was performed in the usual way. A blood sample was taken from the cubital vein while the retrobulbar anaesthetic was taking effect.
The samples were frozen, heat-insulated, packed in carbon-dioxide ice, and sent in a single consignment from Lahti to the Research Centre Laake-Medipolar, Turku, where the drug determinations Trimethoprim and sulphamethoxazole in the aqueous humour SMZ was determined chemically by spectrophotometry (Bratton and Marshall, 1939) .
TM was assayed by an agar plate diffusion technique using Bacillus pumilus as the test organism. The zone diameters of inhibition were measured and compared to standards after the plates had been incubated at 370C for about i8 hrs. The standard solutions used for the aqueous assays were o-8, 0-5. 0-25. OI5, and-Ioo ,g./ml. and for the serum assays 0-5, 0-25. 0-15. 010. 0-05, and 0-025 ,ug./ml. The sensitivity of the assays was slightly below the lowest standard point.
Results
The results of the rabbit tests are presented in Table I . Penetration of TM into the aqueous was demonstrable in all but one test animal. The concentration in the aqueous was 9 to 2 I per cent of the serum level. SMZ penetrated into the aqueous in all the test animals and the concentration was from 9 to 2 I per cent. of the serum concentration. The results for the samples taken from the cataract patients are given in Table II.  Table II Serum 
